Our findings provide evidence that IND6 holds potential as treatment of vascular complications associated with obesity, where intracellular ATP levels are high due to the energy surplus and AMPK activity is reduced5. Here, PRKAA1 is linked to obesity due to melanocortin 4 receptor deficiency.